Pharmacological interventions for insomnia disorder in adults

失眠症 心理干预 医学 精神科
作者
Matthew J. Reid,Andrew S. Huhn,Patrick H. Finan
出处
期刊:The Lancet [Elsevier BV]
卷期号:400 (10366): 1845-1846 被引量:3
标识
DOI:10.1016/s0140-6736(22)02031-1
摘要

A meta-analysis published in 2022 by Franco de Crescenzo and colleagues1De Crescenzo F D'Alò GL Ostinelli EG et al.Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.Lancet. 2022; 400: 170-184Summary Full Text Full Text PDF PubMed Scopus (72) Google Scholar suggested poor efficacy of pharmacotherapeutics in the treatment of insomnia disorder, which sits contrary to the outcomes of earlier meta-analyses. Despite such striking findings from transparent and rigorous methodology, there are multiple clinical scenarios and nuances in the pharmacotherapeutic treatment of sleep disorders that should also be considered. At a basic level, there can be a logically precarious assumption that patients' responses to a given intervention are homogeneous, yet insomnia is phenomenologically diverse, with phenotypes that might require different treatment approaches. For example, patients classified according to the short sleep phenotype, a severe phenotype characterised by insomnia with objective short sleep duration, respond poorly to cognitive behavioural therapy (CBT) for insomnia, which is the gold standard non-pharmacological therapeutic that is highly effective for many patients with insomnia who do not share this specific phenotype. However, trials comparing trazadone and CBT for insomnia in objective short sleepers concluded that only trazadone, and not CBT for insomnia, was effective at increasing total sleep time in this population.2Vgontzas AN Puzino K Fernandez-Mendoza J Krishnamurthy VB Basta M Bixler EO Effects of trazodone versus cognitive behavioral therapy in the insomnia with short sleep duration phenotype: a preliminary study.J Clin Sleep Med. 2020; 16: 2009-2019Crossref PubMed Scopus (32) Google Scholar Insomnia has consistently high rates of co-occurrence among medical and psychiatric disorders. Although the meta-analysis used secondary insomnia as an exclusion criterion, the third edition of the International Classification of Sleep Disorders and the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders no longer recognise secondary insomnia, instead classifying all cases, irrespective of comorbidity, as insomnia disorder. This distinction is clinically important because comorbid insomnia often necessitates pharmacological interventions, due to the poor efficacy of non-pharmacological alternatives. Many clinicians might interpret such findings as universal superiority of CBT for insomnia over pharmacotherapy; however, adherence to CBT for insomnia activities (eg, maintaining strict waking times) relies on intact self-efficacy and motivation, which is often not possible for people with psychiatric disorders such as depressive disorders and substance use disorders. Patients with insomnia who rate low in measures of self-efficacy and high in perceptions of boredom or irritation from CBT for insomnia report worse outcomes than patients who rate high in measures of self-efficacy and low in perceptions of boredom or irritation from CBT for insomnia.3Mitchell MD Gehrman P Perlis M Umscheid CA Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review.BMC Fam Pract. 2012; 13: 40Crossref PubMed Scopus (350) Google Scholar Drop-out rates in CBT for insomnia trials for people with major depressive disorder have been as high as 64%,4Cheng P Kalmbach DA Tallent G Joseph CL Espie CA Drake CL Depression prevention via digital cognitive behavioral therapy for insomnia: a randomized controlled trial.Sleep. 2019; 42zsz150Crossref Scopus (84) Google Scholar and 50% of patients with post-traumatic stress disorder-associated insomnia still exhibited symptoms following a standardised course of CBT for insomnia.5Zayfert C DeViva JC Residual insomnia following cognitive behavioral therapy for PTSD.J Trauma Stress. 2004; 17: 69-73Crossref PubMed Scopus (258) Google Scholar Furthermore, in a study published in 20226Huhn AS Finan PH Gamaldo CE et al.Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper.Sci Transl Med. 2022; 14eabn8238Crossref PubMed Scopus (15) Google Scholar of patients with opioid use disorder undergoing medically supervised withdrawal (published after the meta-analysis was conducted), the dual orexin receptor antagonist suvorexant showed large improvements in subjective total sleep times (76·6% increase), objective total sleep times, and opioid cravings.6Huhn AS Finan PH Gamaldo CE et al.Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taper.Sci Transl Med. 2022; 14eabn8238Crossref PubMed Scopus (15) Google Scholar Indeed, de Crescenzo and colleagues acknowledge the challenges associated with prescribing opioids in combination with hypnotic agents in their Discussion,1De Crescenzo F D'Alò GL Ostinelli EG et al.Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis.Lancet. 2022; 400: 170-184Summary Full Text Full Text PDF PubMed Scopus (72) Google Scholar and such interventions could offer viable alternatives in this population. We encourage clinicians to consider the cases presented here, in which the efficacy of insomnia treatments might be optimally evaluated in study designs that allow for nuance and analysis across multiple levels (eg, biological and behavioural phenotypes). MJR has received research funding from the British Sleep Society. ASH has received research grant funding from The National Institutes of Health and Ashley Addiction Treatment. PHF has received research grant support from the National Institutes of Health. Pharmacological interventions for insomnia disorder in adults – Authors' replyWe thank Matthew J Reid and colleagues for commenting on our systematic review and network meta-analysis.1 Although the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders does not use the term secondary insomnia, the criteria for insomnia disorder are more nuanced than Reid and colleagues suggest. For example, the diagnosis is excluded if a coexisting mental disorder can "adequately explain the predominant complaint of insomnia", which is not always an easy judgement. We agree, however, that the presence of genuine comorbidity is important because, as Reid and colleagues point out, it could have implications for the utility of cognitive behavioural therapy for insomnia versus pharmacotherapy, and thereby aid individual treatment decision making. Full-Text PDF
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
YZ发布了新的文献求助10
1秒前
精明的忆灵完成签到,获得积分20
1秒前
英勇的幻枫完成签到 ,获得积分10
1秒前
KONG发布了新的文献求助10
1秒前
1秒前
2秒前
2秒前
3秒前
sevenvictory应助StonesKing采纳,获得10
3秒前
迷路幻柏完成签到,获得积分10
4秒前
4秒前
5秒前
5秒前
sincere-辉完成签到,获得积分10
6秒前
爆米花应助静越采纳,获得10
6秒前
小赵发布了新的文献求助10
7秒前
楼松思完成签到,获得积分10
7秒前
luluyu完成签到,获得积分10
7秒前
Melt完成签到,获得积分10
7秒前
ottsannn发布了新的文献求助10
7秒前
Jerlly完成签到,获得积分0
7秒前
9秒前
耍酷的小土豆完成签到,获得积分10
10秒前
李健应助Albertxkcj采纳,获得10
10秒前
陈思雨发布了新的文献求助10
10秒前
HHR33完成签到,获得积分10
11秒前
11秒前
善学以致用应助罗小甜采纳,获得10
12秒前
亨利公爵发布了新的文献求助10
12秒前
甜美迎南发布了新的文献求助10
13秒前
13秒前
13秒前
温婉发布了新的文献求助10
14秒前
hredy完成签到,获得积分20
14秒前
星辰大海应助不安的橘子采纳,获得10
14秒前
15秒前
Jasper应助xkx采纳,获得10
15秒前
胆小无助但能吃完成签到,获得积分10
15秒前
15秒前
yznfly应助怡然的向南采纳,获得30
16秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Picture Books with Same-sex Parented Families: Unintentional Censorship 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3969458
求助须知:如何正确求助?哪些是违规求助? 3514286
关于积分的说明 11173363
捐赠科研通 3249652
什么是DOI,文献DOI怎么找? 1794948
邀请新用户注册赠送积分活动 875501
科研通“疑难数据库(出版商)”最低求助积分说明 804836